2.835USD+1.98%Mkt Cap: 183.27M USDP/E: —Last update: 2026-05-26
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions…
Industry Peers
Medical Devices151.38BUSDP/E 24.3
119.84BUSDP/E 36.2
86.12BUSDP/E 24.2
53.79BSEKP/E 100.1
52.47BSEKP/E 22.3
51.50BDKKP/E 21.8
50.54BUSDP/E 47.4
38.75BEURP/E 18.3
Indicators:|
Key Statistics
Company
Market Cap183.27M USD
Enterprise Value203.99M USD
Revenue (TTM)207.32M USD
Gross Profit169.75M USD
Net Income (TTM)-59.00M USD
Revenue/Share3.252 USD
Last Price2.835 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees450
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-3.16
PEG—
EV/EBITDA-4.28
EV/Revenue0.98
P/S0.89
P/B2.38
EPS (TTM)-0.96
EPS (Forward)-0.90
52W Range
1.17025% of range7.780
52W High7.780 USD
52W Low1.170 USD
Profitability
Gross Margin79.81%
Oper. Margin-36.37%
EBITDA Margin-23.00%
Profit Margin-27.74%
ROE-67.56%
ROA-30.96%
Growth
Revenue Growth-10.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-15.97M USD
CapEx (TTM)13.52M USD
FCF Margin-2.78%
FCF Yield-3.15%
Net Debt19.75M USD
Net Debt/EBITDA-0.41
Balance Sheet
Debt/Equity0.82
Current Ratio3.58
Quick Ratio2.40
Book Value/Sh1.191 USD
Cash/Share0.7990 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.8 (Hold)
Target (Mean)4.000 USD
Target Range2.000 USD – 7.000 USD
# Analysts3
Ownership
Shares Out.64.87M
Float48.30M
Insiders25.07%
Institutions57.10%
Short Interest
Short Ratio4.3d
Short % Float7.66%
Short % Out.6.11%
Shares Short3.96M
Short (prev mo.)4.41M
Technical
SMA 501.812 (+56.4%)
SMA 2003.718 (-23.8%)
Beta1.11
S&P 52W Chg28.31%
Avg Vol (30d)544.06K
Avg Vol (10d)771.69K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—